OTC and ornithine carbamoyltransferase deficiency: LSP1 promoter was used in preclinical studies of ornithine transcarbamylase (OTC) deficiency in mice and for the expression of piggyBac transposase for editing OTC-deficient patient-derived primary human hepatocytes [271,272,273].